Trials / Not Yet Recruiting
Not Yet RecruitingNCT07531628
A Study to Test How Verducatib is Taken up in the Body of Healthy Chinese Participants
Pharmacokinetics, Safety, and Tolerability Study of Multiple Oral Doses of Verducatib for 4 Weeks in Healthy Chinese Male and Female Trial Participants (Open-label, Single Arm)
- Status
- Not Yet Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (estimated)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
To assess pharmacokinetics, safety, and tolerability of multiple oral doses of verducatib in healthy Chinese male and female trial participants in order to facilitate the clinical development of verducatib in China.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Verducatib | Verducatib |
Timeline
- Start date
- 2026-07-13
- Primary completion
- 2026-08-10
- Completion
- 2026-10-14
- First posted
- 2026-04-15
- Last updated
- 2026-04-15
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07531628. Inclusion in this directory is not an endorsement.